Novartis AG (NVS)
152.84
-1.19
(-0.77%)
USD |
NYSE |
Apr 06, 16:00
152.86
+0.02
(+0.01%)
After-Hours: 20:00
Novartis Market Cap : 289.43B for April 6, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Roche Holding AG | 319.23B |
| Amgen, Inc. | 181.80B |
| AstraZeneca PLC | 313.35B |
| Biogen, Inc. | 24.57B |
| Gilead Sciences, Inc. | 174.48B |
Market Cap Related Metrics
| PE Ratio | 21.11 |
| PS Ratio | 5.410 |
| PEG Ratio | 0.9361 |
| Price to Book Value | 6.274 |
| Price to Free Cash Flow | 19.32 |
| Price | 152.84 |
| Earnings Yield | 4.74% |
| PEGY Ratio | 0.9361 |
| Operating PE Ratio | 17.36 |
| Normalized PE Ratio | 20.07 |